Contact Us
Investors
Media
Media Resources
SEC Filings
Press Releases
Email Alerts
Contact Us
Careers
Join Our Team
Current Opportunities
The Candidate Process
Life at Lantheus
Taking Health to Heart
Our Values
Our Global Headquarters
Employee Benefits
Contact Us
About Us
See the Difference
Leadership
History
Corporate Citizenship
Grants
Locations
Products
Overview
Overview
DEFINITY
®
VIALMIX
®
PINSYNC
®
TechneLite
®
Xenon-133
Calidose™ Dispenser System
NEUROLITE
®
Thallium-201
QUADRAMET
®
Cardiolite
®
Gallium-67
Fludeoxyglucose F 18 Injection
Manufacturing & Supply Chain
Customer Service
Customer Service
FAQs
Standard Conditions of Sale
Reimbursement
Radiochemical Products
Radiochemical Products
Cobalt-57
Lead-203
Gallium-67
Xenon-133
Patent Information
Pipeline
New Product Development
Flurpiridaz F 18
LMI 1195 (CNA)
Clinical Development for Existing Products
Art of Imaging
Overview
History of Innovation
Medical Imaging 101
Echocardiography
Nuclear Imaging
Contact Us
Investors
Media
Media Resources
SEC Filings
Press Releases
Email Alerts
Contact Us
Careers
Join Our Team
Current Opportunities
The Candidate Process
Life at Lantheus
Taking Health to Heart
Our Values
Our Global Headquarters
Employee Benefits
Contact Us
Products
Supply Updates
Products
Overview
DEFINITY
®
VIALMIX
®
PINSYNC
®
TechneLite
®
Xenon-133
Calidose™ Dispenser System
NEUROLITE
®
Thallium-201
QUADRAMET
®
Cardiolite
®
Gallium-67
Fludeoxyglucose F 18 Injection
Manufacturing & Supply Chain
Customer Service
FAQs
Standard Conditions of Sale
Reimbursement
Radiochemical Products
Cobalt-57
Lead-203
Gallium-67
Xenon-133
Patent Information